Shaofeng Zhan

673 total citations
40 papers, 455 citations indexed

About

Shaofeng Zhan is a scholar working on Infectious Diseases, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shaofeng Zhan has authored 40 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shaofeng Zhan's work include Computational Drug Discovery Methods (7 papers), Mosquito-borne diseases and control (7 papers) and COVID-19 Clinical Research Studies (6 papers). Shaofeng Zhan is often cited by papers focused on Computational Drug Discovery Methods (7 papers), Mosquito-borne diseases and control (7 papers) and COVID-19 Clinical Research Studies (6 papers). Shaofeng Zhan collaborates with scholars based in China, United Kingdom and Canada. Shaofeng Zhan's co-authors include Xiaohong Liu, Yong Jiang, Hui-Ting Huang, Xiufang Huang, Yanni Lai, Jing He, Weitao Chen, Qian Yan, Geng Li and Tiantian Han and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Shaofeng Zhan

38 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaofeng Zhan China 12 136 120 76 61 60 40 455
Zhongde Zhang China 12 136 1.0× 105 0.9× 58 0.8× 40 0.7× 46 0.8× 36 459
Nawal Helmi Saudi Arabia 11 129 0.9× 172 1.4× 91 1.2× 36 0.6× 25 0.4× 40 643
Yanyan Cen China 17 241 1.8× 56 0.5× 124 1.6× 75 1.2× 61 1.0× 23 632
Soo Young Byun South Korea 8 161 1.2× 348 2.9× 57 0.8× 83 1.4× 31 0.5× 8 593
Haibo Zhou China 6 74 0.5× 124 1.0× 59 0.8× 31 0.5× 53 0.9× 13 353
Jiayin Qiu China 13 180 1.3× 294 2.5× 77 1.0× 58 1.0× 33 0.6× 32 731
Justin Shields Canada 9 252 1.9× 353 2.9× 93 1.2× 93 1.5× 75 1.3× 12 743
Yu Hao China 11 158 1.2× 43 0.4× 66 0.9× 86 1.4× 67 1.1× 29 418
Priyanka Firmal India 7 133 1.0× 258 2.1× 96 1.3× 59 1.0× 15 0.3× 10 568

Countries citing papers authored by Shaofeng Zhan

Since Specialization
Citations

This map shows the geographic impact of Shaofeng Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaofeng Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaofeng Zhan more than expected).

Fields of papers citing papers by Shaofeng Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaofeng Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaofeng Zhan. The network helps show where Shaofeng Zhan may publish in the future.

Co-authorship network of co-authors of Shaofeng Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Shaofeng Zhan. A scholar is included among the top collaborators of Shaofeng Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaofeng Zhan. Shaofeng Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaofang, Xinxin Zhang, Hui-Ting Huang, et al.. (2025). Elucidating the underlying therapeutic mechanism of Feikang prescription on chronic obstructive pulmonary disease: insights from a comprehensive analysis. Phytomedicine. 147. 157175–157175. 1 indexed citations
2.
Yan, Qian, et al.. (2025). Integration analysis of transcriptomics revealed NETosis heterogeneity and Ncf1 as a prognostic biomarker in neutrophil asthma. International Immunopharmacology. 161. 115004–115004.
4.
Yan, Qian, et al.. (2024). Integrative analysis of network pharmacology and proteomics reveal the protective effect of Xiaoqinglong Decotion on neutrophilic asthma. Journal of Ethnopharmacology. 330. 118102–118102. 2 indexed citations
5.
6.
Li, Xuchun, Qing Wang, Jiewen Huang, et al.. (2024). Posaconazole nanocrystals dry powder inhalers for the local treatment of invasive pulmonary aspergillosis. International Journal of Pharmaceutics. 668. 124938–124938. 2 indexed citations
7.
Yan, Qian, et al.. (2023). Network-based analysis between SARS-CoV-2 receptor ACE2 and common host factors in COVID-19 and asthma: Potential mechanistic insights. Biomedical Signal Processing and Control. 87. 105502–105502. 2 indexed citations
8.
Jiao, Xin, et al.. (2023). Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC. Frontiers in Endocrinology. 14. 1187882–1187882. 9 indexed citations
9.
Ma, Zhimin, Xuejuan Zhang, Xiubing Zhang, et al.. (2023). Supercritical antisolvent-fluidized bed for the preparation of dry powder inhaler for pulmonary delivery of nanomedicine. International Journal of Pharmaceutics. 648. 123580–123580. 11 indexed citations
10.
Jiao, Xin, et al.. (2023). A bidirectional Mendelian randomization study of sarcopenia-related traits and inflammatory bowel diseases. Frontiers in Immunology. 14. 1240811–1240811. 2 indexed citations
11.
Yan, Qian, Yong Jiang, Peiwen Zhou, et al.. (2022). Transcriptomic reveals the ferroptosis features of host response in a mouse model of Zika virus infection. Journal of Medical Virology. 95(1). e28386–e28386. 21 indexed citations
13.
Jiang, Yong, Qian Yan, Hui-Ting Huang, et al.. (2022). Insights into potential mechanisms of asthma patients with COVID-19: A study based on the gene expression profiling of bronchoalveolar lavage fluid. Computers in Biology and Medicine. 146. 105601–105601. 10 indexed citations
14.
Zhang, Tian, et al.. (2022). Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Frontiers in Immunology. 13. 952987–952987. 19 indexed citations
16.
Li, Laurent, Zizhao Lao, Jiangtao Xu, et al.. (2021). Cinnamic acid inhibits Zika virus by inhibiting RdRp activity. Antiviral Research. 192. 105117–105117. 34 indexed citations
17.
Huang, Xiufang, et al.. (2021). Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2. Frontiers in Pharmacology. 12. 631206–631206. 27 indexed citations
18.
Zhang, Wen, Xiao‐Ping Lai, Shaofeng Zhan, et al.. (2019). Asprellcosides B of Ilex asprella Inhibits Influenza A Virus Infection by Blocking the Hemagglutinin- Mediated Membrane Fusion. Frontiers in Microbiology. 9. 3325–3325. 11 indexed citations
19.
Jin, Hailong, Chi–Rong Li, Li Xiao, et al.. (2012). Clinical Relevance of sHLA-G-Mediated With Better Graft Acceptance in Early Posttransplantation. Transplantation Proceedings. 44(5). 1259–1261. 8 indexed citations
20.
Zhan, Shaofeng. (2008). Clinical Research on Efficacy of Acutely Exacerbated Chronic Obstructive Pulmonary Disease(AECOPD) with Modified Weijing Decoction. Zhonghua zhongyiyao xuekan. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026